BioNTech SE (BNTX)
95.87
-0.82
(-0.85%)
USD |
NASDAQ |
Sep 16, 16:00
96.27
+0.40
(+0.42%)
After-Hours: 20:00
BioNTech Market Cap : 24.08B for Sept. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 15, 2026 | 24.29B |
| September 14, 2026 | 24.83B |
| September 11, 2026 | 24.30B |
| September 10, 2026 | 24.22B |
| September 09, 2026 | 24.65B |
| September 08, 2026 | 24.78B |
| September 04, 2026 | 26.06B |
| September 03, 2026 | 25.84B |
| September 02, 2026 | 26.08B |
| September 01, 2026 | 25.61B |
| August 31, 2026 | 25.52B |
| August 28, 2026 | 25.64B |
| August 27, 2026 | 27.98B |
| August 26, 2026 | 28.28B |
| August 25, 2026 | 28.65B |
| August 24, 2026 | 28.34B |
| August 21, 2026 | 29.28B |
| August 20, 2026 | 27.86B |
| August 19, 2026 | 28.42B |
| August 18, 2026 | 23.30B |
| August 17, 2026 | 23.01B |
| August 14, 2026 | 23.38B |
| August 13, 2026 | 23.14B |
| August 12, 2026 | 23.30B |
| August 11, 2026 | 23.31B |
| Date | Value |
|---|---|
| August 10, 2026 | 23.31B |
| August 07, 2026 | 23.53B |
| August 06, 2026 | 22.91B |
| August 05, 2026 | 23.16B |
| August 04, 2026 | 22.95B |
| August 03, 2026 | 23.17B |
| July 31, 2026 | 22.91B |
| July 30, 2026 | 23.48B |
| July 29, 2026 | 23.51B |
| July 28, 2026 | 23.38B |
| July 27, 2026 | 23.04B |
| July 24, 2026 | 22.59B |
| July 23, 2026 | 23.28B |
| July 22, 2026 | 23.22B |
| July 21, 2026 | 23.35B |
| July 20, 2026 | 23.31B |
| July 17, 2026 | 23.13B |
| July 16, 2026 | 23.15B |
| July 15, 2026 | 23.26B |
| July 14, 2026 | 22.86B |
| July 13, 2026 | 22.78B |
| July 10, 2026 | 23.14B |
| July 09, 2026 | 23.51B |
| July 08, 2026 | 23.65B |
| July 07, 2026 | 23.84B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 58.10B |
| Biodexa Pharmaceuticals Plc | 7.282B |
| MediGene AG | 1.474M |
| NuCana Plc | 5.602M |
| InflaRx NV | 300.63M |
Market Cap Related Metrics
| PS Ratio | 7.671 |
| PEG Ratio | -0.0313 |
| Price to Book Value | 1.186 |
| Price to Free Cash Flow | 55.90 |
| Price | 95.87 |
| Earnings Yield | -8.19% |
| PEGY Ratio | -0.0313 |